FGEN vs PNC · rev $29.6M vs P/E 14, rev $6.88B
FibroGen Inc (FGEN) versus PNC Financial Services Group Inc (PNC) — a side-by-side from cached financials, not a winner call.
FibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
PNC Financial Services Group Inc (PNC) is a banks - regional company listed on US.
Latest reported FGEN revenue for 2024-12-31 was $29.6M. Net income was -$47.6M. Revenue was down 36.7% from 2023-12-31 to 2024-12-31. FGEN currently screens at market cap $39.3M.
Latest reported PNC revenue for 2026-06-30 was $6.88B. Net income was $2.04B. Revenue was up 11.5% from 2026-03-31 to 2026-06-30. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
FGEN currently screens at market cap $39.3M. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
Not investment advice. Open the FGEN and PNC stock pages for the full models.
Not investment advice.